The Vanguard International High Dividend Yield ETF holds top positions in companies including Hoffmann-La Roche, HSBC, Novartis, Royal Bank of Canada, and Nestlé, with weak dollar impacting distribution.

The entities involved

• Hoffmann-La Roche →

  Swiss healthcare company

  • Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44
  • Hoffmann-La Roche opened a new R&D center in Boston.Sat 11:08
• HSBC →

  British multinational bank

  • HSBC utilized its Orion platform for a bond issuance, which was reported by Reuters and involves S&P sovereign ratings for Hong Kong.Mon 06:51
  • Alphabet filed a disclosure with the SEC and HSBC partnered with Google Cloud for AI.Mon 05:51
• Novartis →

  Swiss-American multinational pharmaceutical corporation

  • Novartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Sat 01:46
  • GSK and Novartis are identified as major pharmaceutical companies.Fri 02:16
• Nestlé →

  Swiss multi-national food and beverage company

  Nothing else this week.

Related events

• The Fidelity Canadian High Dividend ETF holds Enbridge, Royal Bank of Canada, and Toronto-Dominion Bank as top dividend payers.Jul 2
• Royal Bank of Canada increased its holdings in the iShares Morningstar U.S. Equity ETF on May 28, 2026.Jun 7
• Royal Bank of Canada grew its stake in the Schwab US Dividend Equity ETF on July 4, 2026.Jul 4
• Royal Bank of Canada increased its holdings in the American Century ETF on August 25, 2026.Aug 26
• Royal Bank of Canada raised holdings in the JPMorgan BetaBuilders U.S. Mid Cap Equity ETF.Sep 15